Biotoxtech Co Stock Z Score
086040 Stock | KRW 5,600 50.00 0.88% |
Biotoxtech |
Biotoxtech Co Company Z Score Analysis
Biotoxtech's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Biotoxtech Z Score | 34.2 |
Most of Biotoxtech's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotoxtech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
In accordance with the company's disclosures, Biotoxtech Co has a Z Score of 34.2. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The z score for all Republic of Korea stocks is notably lower than that of the firm.
Biotoxtech Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotoxtech's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotoxtech could also be used in its relative valuation, which is a method of valuing Biotoxtech by comparing valuation metrics of similar companies.Biotoxtech is currently under evaluation in z score category among related companies.
Biotoxtech Fundamentals
Return On Equity | 13.27 | |||
Return On Asset | 0.0343 | |||
Profit Margin | 0.13 % | |||
Operating Margin | 0.12 % | |||
Current Valuation | 156.1 B | |||
Shares Outstanding | 14.56 M | |||
Shares Owned By Insiders | 26.95 % | |||
Shares Owned By Institutions | 0.68 % | |||
Price To Earning | 47.60 X | |||
Price To Sales | 3.12 X | |||
Revenue | 34.09 B | |||
Gross Profit | 6.4 B | |||
EBITDA | 5.67 B | |||
Net Income | 6.98 B | |||
Cash And Equivalents | 18.59 B | |||
Cash Per Share | 803.72 X | |||
Total Debt | 2.01 B | |||
Debt To Equity | 47.30 % | |||
Current Ratio | 0.71 X | |||
Book Value Per Share | 1,604 X | |||
Cash Flow From Operations | 4.35 B | |||
Target Price | 15000.0 | |||
Beta | 0.84 | |||
Market Capitalization | 115.73 B | |||
Total Asset | 90.74 B | |||
Retained Earnings | (4.82 B) | |||
Working Capital | (4.75 B) | |||
Current Asset | 13.46 B | |||
Current Liabilities | 18.21 B | |||
Z Score | 34.2 | |||
Net Asset | 90.74 B |
About Biotoxtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotoxtech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotoxtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotoxtech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |